Viremia, antigenemia, and serum antibodies in rhesus macaques infected with simian retrovirus type 1 and their relationship to disease course. NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Viremia, antigenemia, and serum antibodies in rhesus macaques infected with simian retrovirus type 1 and their relationship to disease course.

Lab Invest. 1987 Jun;56(6):591-7. Unique Identifier : AIDSLINE MED/87255842
Kwang HS; Pedersen NC; Lerche NW; Osborn KG; Marx PA; Gardner MB


Abstract: The course of simian retrovirus type 1 (SRV-1) infection was studied in 14 experimentally inoculated juvenile rhesus monkeys. Viral transmembrane protein antigenemia and antibodies to whole virus were measured by enzyme linked immunosorbent assay and correlated with the clinical course of disease and virus isolation. Based on these parameters, animals with simian retrovirus type 1-induced disease were divided into three categories: monkeys dying within a few months of fulminating simian acquired immune deficiency syndrome in the face of a high level persistent antigenemia and viremia, and a nondetectable serum antibody response; monkeys that developed a milder form of simian acquired immune deficiency syndrome but remained alive in spite of a chronic low-grade antigenemia and viremia and only a transient initial antibody response; and monkeys that never became ill and that were either transiently or nontransiently viremic and antigenemic. This latter group developed high levels of serum antibodies. The outcome of simian retrovirus type 1-induced disease was similar to that described for feline leukemia virus infection of cats, another retroviral disease of animals. The disease course differed considerably, however, from that reported for retrovirus-induced human acquired immune deficiency syndrome.
Keywords: Acquired Immunodeficiency Syndrome/MICROBIOLOGY/*VETERINARY Animal Antibodies, Viral/*ANALYSIS Antigens, Viral/*ANALYSIS Enzyme-Linked Immunosorbent Assay Female Macaca mulatta Mice Mice, Inbred BALB C Monkey Diseases/IMMUNOLOGY/*MICROBIOLOGY Retroviridae/IMMUNOLOGY/*ISOLATION & PURIF Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Vaccination JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/microbiology/KWDveterinaryanimalantibodies,viral/KWDanalysisantigens,viral/KWDanalysisenzyme-linkedimmunosorbentassayfemalemacacamulattamicemice,inbredbalbcmonkeydiseases/immunology/KWDmicrobiologyretroviridae/immunology/KWDisolation&purifsupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDvaccinationjournalarticle
871030
M87A0354


Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .